Correlations Between Clinical Features and Mouth Opening in Patients With Systemic Sclerosis

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2020 Aug 28

PMID 32851368

Citations 3

Authors

Ipek Turk

Nihan Cuzdan

Volkan Ciftci

Didem Arslan

Ilker Unal

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to investigate the correlations between clinical features and mouth opening in patients with systemic sclerosis (SSc).

Patients And Methods: Eighty patients with SSc (13 males, 67 females; mean age 53.39±11.65 years; range, 31 to 76 years) followed in our clinic were enrolled in the study. Skin involvement was assessed using the modified Rodnan skin score (mRSS), joint/tendon involvement with finger-tip to palm (FTP) distance and interstitial lung disease (ILD) was evaluated with clinical and radiologic methods. The interincisal distance (ID) measurement was used to assess the maximal mouth opening capacity. We examined associations between the ID and clinical features of SSc.

Results: The ID was lower in females compared with males, and in diffuse type compared with the limited type (p<0.001 and p<0.001, respectively). A significant negative correlation was found between the ID with mRSS and FTP distance (p<0.001 and p=0.001, respectively). The ID was lower in patients with ILD than in patients without ILD (p=0.006). A formula was constituted to predict the maximal mouth opening of the patient with regression analysis. According to the formula, being male was associated with an increase of 6.14 mm, the presence of ILD with a decrease of 3.19 mm, every 10 mm increment in mRSS with a decrease of 3.72 mm and FTP distance >0 mm with a decrease of 5.13 mm in mouth opening.

Conclusion: Microstomia is associated with low quality of life in patients with SSc. In our study, sex, ILD, mRSS, and FTP distance were observed to be the most important factors that were related with mouth opening in patients with SSc.

Citing Articles

Periodontitis Burden in Diffuse Versus Limited Systemic Sclerosis Subtypes: A Pilot Study.

Stanomir A, Micu I, Picos A, Roman A, Soanca A, Onet D Curr Health Sci J. 2023; 49(2):280-287.

PMID: 37779832 PMC: 10541067. DOI: 10.12865/CHSJ.49.02.280.

Dental implants in patients suffering from systemic sclerosis: a retrospective analysis of clinical outcomes in a case series with 24 patients.

Jackowski J, Strietzel F, Hunzelmann N, Parwani P, Jackowski A, Benz K Int J Implant Dent. 2021; 7(1):118.

PMID: 34958444 PMC: 8712283. DOI: 10.1186/s40729-021-00398-9.

Oral manifestations of patients with systemic sclerosis: a meta-analysis for case-controlled studies.

Zhang S, Zhu J, Zhu Y, Zhang X, Wu R, Li S BMC Oral Health. 2021; 21(1):250.

PMID: 33971854 PMC: 8108335. DOI: 10.1186/s12903-021-01603-2.

References

Amin K, Clarke A, Sivakumar B, Puri A, Fox Z, Brough V . The psychological impact of facial changes in scleroderma. Psychol Health Med. 2011; 16(3):304-12. DOI: 10.1080/13548506.2010.540250. View

Medsger Jr T, Bombardieri S, Czirjak L, Scorza R, Della Rossa A, Bencivelli W . Assessment of disease severity and prognosis. Clin Exp Rheumatol. 2003; 21(3 Suppl 29):S42-6. View

Crincoli V, Fatone L, Fanelli M, Rotolo R, Chiala A, Favia G . Orofacial Manifestations and Temporomandibular Disorders of Systemic Scleroderma: An Observational Study. Int J Mol Sci. 2016; 17(7). PMC: 4964558. DOI: 10.3390/ijms17071189. View

Pizzo G, Scardina G, Messina P . Effects of a nonsurgical exercise program on the decreased mouth opening in patients with systemic scleroderma. Clin Oral Investig. 2003; 7(3):175-8. DOI: 10.1007/s00784-003-0216-5. View

Torok K, Baker N, Lucas M, Domsic R, Boudreau R, Medsger Jr T . Reliability and validity of the delta finger-to-palm (FTP), a new measure of finger range of motion in systemic sclerosis. Clin Exp Rheumatol. 2010; 28(2 Suppl 58):S28-36. PMC: 2935276. View

Clements P, Furst D, Wong W, Mayes M, White B, Wigley F . High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial. Arthritis Rheum. 1999; 42(6):1194-203. DOI: 10.1002/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7. View

Vayssairat M, Hidouche D, Abdoucheli-Baudot N, Gaitz J . Clinical significance of subcutaneous calcinosis in patients with systemic sclerosis. Does diltiazem induce its regression?. Ann Rheum Dis. 1998; 57(4):252-4. PMC: 1752566. DOI: 10.1136/ard.57.4.252. View

Walker U, Tyndall A, Czirjak L, Denton C, Farge-Bancel D, Kowal-Bielecka O . Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis. 2007; 66(6):754-63. PMC: 1954657. DOI: 10.1136/ard.2006.062901. View

Schneider F, Gruden J, Tazelaar H, Leslie K . Pleuropulmonary pathology in patients with rheumatic disease. Arch Pathol Lab Med. 2012; 136(10):1242-52. DOI: 10.5858/arpa.2012-0248-SA. View

10.

Matarese G, Isola G, Alibrandi A, Lo Gullo A, Bagnato G, Cordasco G . Occlusal and MRI characterizations in systemic sclerosis patients: A prospective study from Southern Italian cohort. Joint Bone Spine. 2015; 83(1):57-62. DOI: 10.1016/j.jbspin.2015.04.014. View

11.

Boulman N, Slobodin G, Rozenbaum M, Rosner I . Calcinosis in rheumatic diseases. Semin Arthritis Rheum. 2005; 34(6):805-12. DOI: 10.1016/j.semarthrit.2005.01.016. View

12.

Wood G, Branco J . A comparison of three methods of measuring maximal opening of the mouth. J Oral Surg. 1979; 37(3):175-7. View

13.

Tolosa-Vilella C, Morera-Morales M, Simeon-Aznar C, Mari-Alfonso B, Colunga-Arguelles D, Callejas Rubio J . Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry. Semin Arthritis Rheum. 2016; 46(2):200-208. DOI: 10.1016/j.semarthrit.2016.04.007. View

14.

Lei L, Zhao C, Qin F, He Z, Wang X, Zhong X . Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol. 2016; 34 Suppl 100(5):14-22. View

15.

Cruz-Dominguez M, Garcia-Collinot G, Saavedra M, Medina G, Carranza-Muleiro R, Vera-Lastra O . Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis. Clin Rheumatol. 2016; 36(1):111-117. DOI: 10.1007/s10067-016-3412-9. View

16.

Baron M, Hudson M, Steele R . Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database. J Rheumatol. 2009; 36(12):2737-43. DOI: 10.3899/jrheum.090694. View

17.

Maddali Bongi S, Del Rosso A, Galluccio F, Tai G, Sigismondi F, Passalacqua M . Efficacy of a tailored rehabilitation program for systemic sclerosis. Clin Exp Rheumatol. 2009; 27(3 Suppl 54):44-50. View

18.

Guillevin L, Hunsche E, Denton C, Krieg T, Schwierin B, Rosenberg D . Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. Clin Exp Rheumatol. 2013; 31(2 Suppl 76):71-80. View

19.

Tas D, Erken E, Sakalli H, Yucel A . Evaluating hand in systemic sclerosis. Rheumatol Int. 2011; 32(11):3581-6. DOI: 10.1007/s00296-011-2205-3. View

20.

Bartoli F, Fiori G, Braschi F, Amanzi L, Bruni C, Blagojevic J . Calcinosis in systemic sclerosis: subsets, distribution and complications. Rheumatology (Oxford). 2016; 55(9):1610-4. DOI: 10.1093/rheumatology/kew193. View